Phlegm dispelling

Phlegm dispelling is a therapeutic action or pharmacological category rather than a specific molecular target like a receptor or enzyme. It describes the physiological process of facilitating the clearance of excessive or viscous mucus from the respiratory tract, typically through the use of expectorants or mucolytic agents [StatPearls, NIH]. In Traditional Chinese Medicine (TCM), the term 'Hua Tan' (phlegm dispelling) refers to a broad strategy for resolving pathological fluids and metabolic byproducts that contribute to respiratory and cardiovascular distress [Zhang et al., 2020]. Modern drugs achieve this effect by breaking disulfide bonds in mucin proteins to reduce viscosity or by stimulating airway glands to increase the volume of secretions for easier expectoration [PubMed, NIH]. While not a single molecule, this functional effect involves several biological components, including gel-forming mucins like MUC5AC and MUC5B, as well as ciliary motor proteins and ion transporters such as CFTR [UniProt, PubMed]. Drugs that exert a phlegm-dispelling effect, such as guaifenesin and acetylcysteine, are vital in the management of respiratory conditions characterized by congestion and impaired drainage [StatPearls]. Common clinical applications include the treatment of chronic obstructive pulmonary disease (COPD), bronchitis, and cystic fibrosis [NIH].

Other names

Expectorant activityMucolytic activityHua TanPhlegm resolvingMucokinetic action

Cleaving disulfide bonds in mucin polymers to decrease mucus viscosity (mucolysis), stimulating gastric vagal receptors to increase respiratory tract fluid (expectoration), and enhancing ciliary beat frequency to improve clearance.